PlainPharmaWatch

CMS Open Payments · Tool

Southern Implants North America Inc vs Reflow Medical Inc

Side-by-side comparison of CMS Open Payments data for Program Year 2024. Select different companies below to start a new comparison.

A larger reported total is not "better" or "worse", it is a neutral fact about disclosure volume; a reported payment documents a financial relationship, not evidence of wrongdoing.

Compare Different Companies

vs

Relationship comparison

Which recorded payment profile is more concentrated?

Southern Implants North America Inc has the more concentrated recorded General Payments recipient profile in Program Year 2024: its recipient-distribution HHI is 1,661, versus 862 for the other company. Its single largest recorded recipient represents 35.6% of that company's General Payments recipient total.

HHI summarizes how payments are distributed across recorded recipients: higher means a less evenly distributed recipient pattern. This is a description of CMS-reported General Payments only, not a finding about conduct, prescribing, quality, or wrongdoing. Read it with the recipient count and underlying records below.

Southern Implants North America Inc
HHI 1,661 · top recipient 35.6%
Ranked #824 of 1,838 companies by HHI
Reflow Medical Inc
HHI 862 · top recipient 18.3%
Ranked #1,083 of 1,838 companies by HHI

Payment Overview

Total Payments
$127.2K
% of Industry
0.0%
Transactions
324
Avg per Transaction
$392.53
Recipients
324
Avg per Recipient
$392.53
Payment Types
5
Top Payment Type
Honoraria
Company B

Reflow Medical Inc

Total Payments
$126.3K
% of Industry
0.0%
Transactions
1,044
Avg per Transaction
$120.94
Recipients
1,044
Avg per Recipient
$120.94
Payment Types
3
Top Payment Type
Travel and Lodging

Highlighted values indicate the higher figure for each metric.

Total payments compared

Southern Implants North America Inc vs Reflow Medical Inc - total reported payments in CMS Open Payments PY2024

Southern Implants North Ame…$127.2KReflow Medical Inc$126.3K

General Payment Types Breakdown

Category shares use each company's General Payments total, not the all-tracks (General + Research + Ownership) hero figure.

Southern Implants North America Inc

Honoraria $43.0K

33.8%

Education $30.1K

23.6%

Travel and Lodging $29.9K

23.5%

Food and Beverage $15.8K

12.5%

Consulting Fee $8.3K

6.6%

Reflow Medical Inc

Travel and Lodging $54.1K

42.9%

Food and Beverage $41.6K

32.9%

Consulting Fee $30.6K

24.2%

Top 5 General-Payment Recipients

This list uses CMS detailed General Payments records only; it excludes research and ownership/investment records, so it does not equal the all-category totals above. A reported payment documents a financial relationship, not evidence of wrongdoing; a higher total reflects reporting volume, not conduct. Verify directly at openpaymentsdata.cms.gov.

Southern Implants North America Inc

  1. 1

    STEPHEN CHU

    $45,296.42 · 6 txns

  2. 2

    NICHOLAS EGBERT

    $15,387.17 · 12 txns

  3. 3

    BARRY LEVIN

    $12,088.48 · 6 txns

  4. 4

    CARL DRAGO

    $8,350.00 · 3 txns

  5. 5

    MARK STEINBERG

    $7,507.24 · 5 txns

Reflow Medical Inc

  1. 1

    William Lombardi

    $23,161.65 · 3 txns

  2. 2

    Santhosh Mathews

    $22,729.01 · 42 txns

  3. 3

    Kathleen Kearney

    $12,818.70 · 1 txns

  4. 4

    Mahmood Razavi

    $9,980.26 · 6 txns

  5. 5

    JARROD FRIZZELL

    $3,310.01 · 8 txns

Summary Comparison

Metric Southern Implants North America Inc Reflow Medical Inc
Total Payments $127.2K $126.3K
% of Industry Total 0.0% 0.0%
Transaction Count 324 1,044
Avg per Transaction $392.53 $120.94
Recipient Count 324 1,044
Avg per Recipient $392.53 $120.94
Payment Type Count 5 3
Top Payment Type Honoraria Travel and Lodging

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. All companies in the CMS Open Payments company corpus are available in the selector. Browse all companies →

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.